Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Fazzi

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
European Journal of Haematology|February 14, 2004
Significant co-expression of WT1 and MDR1 genes in acute myeloid leukemia patients at diagnosisS Galimberti, F Guerrini, G Carulli, et al.
Bone Marrow Transplantation|March 21, 2006
Granulocytic sarcoma and subsequent acute leukemia recurrence with different biologic characteristics 5 years after allogeneic bone marrow transplantation for acute myeloid leukemiaM Pelosini, E Benedetti, S Galimberti, et al.
European Review for Medical and Pharmacological Sciences|February 5, 2013
Treatment of pseudoarthrosis of the upper limb using expanded mesenchymal stem cells: a pilot studyS Giannotti, V Bottai, M Ghilardi, et al.
Acta Neurologica|September 1, 1970
[Genetic and immunologic study of 2 families affected by ataxia-telangiectastia of Mme Louis-Bar]G C Guazzi, V Ventruto, M Del Vecchio, et al.
Leukemia|August 31, 2007
Vorinostat and bortezomib significantly inhibit WT1 gene expression in MO7-e and P39 cell linesS Galimberti, M Canestraro, R Khan, et al.
Bone Marrow Transplantation|June 20, 2003
Quantitative molecular evaluation in autotransplant programs for follicular lymphoma: efficacy of in vivo purging by RituximabS Galimberti, F Guerrini, F Morabito, et al.
Bone Marrow Transplantation|April 30, 2002
The role of molecular monitoring in autotransplantation for non-Hodgkin's lymphomaS Galimberti, R Marasca, F Caracciolo, et al.
Journal of Chemotherapy (Florence, Italy)|June 28, 2007
The efficacy of rituximab plus Hyper-CVAD regimen in mantle cell lymphoma is independent of FCgammaRIIIa and FCgammaRIIa polymorphismsS Galimberti, G A Palumbo, F Caracciolo, et al.
Leukemia Research|July 17, 2007
PS-341 (Bortezomib) inhibits proliferation and induces apoptosis of megakaryoblastic MO7-e cellsS Galimberti, M Canestraro, S Pacini, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
European Journal of Haematology|February 14, 2004
Significant co-expression of WT1 and MDR1 genes in acute myeloid leukemia patients at diagnosisS Galimberti, F Guerrini, G Carulli, et al.
Bone Marrow Transplantation|March 21, 2006
Granulocytic sarcoma and subsequent acute leukemia recurrence with different biologic characteristics 5 years after allogeneic bone marrow transplantation for acute myeloid leukemiaM Pelosini, E Benedetti, S Galimberti, et al.
European Review for Medical and Pharmacological Sciences|February 5, 2013
Treatment of pseudoarthrosis of the upper limb using expanded mesenchymal stem cells: a pilot studyS Giannotti, V Bottai, M Ghilardi, et al.
Acta Neurologica|September 1, 1970
[Genetic and immunologic study of 2 families affected by ataxia-telangiectastia of Mme Louis-Bar]G C Guazzi, V Ventruto, M Del Vecchio, et al.
Leukemia|August 31, 2007
Vorinostat and bortezomib significantly inhibit WT1 gene expression in MO7-e and P39 cell linesS Galimberti, M Canestraro, R Khan, et al.
Bone Marrow Transplantation|June 20, 2003
Quantitative molecular evaluation in autotransplant programs for follicular lymphoma: efficacy of in vivo purging by RituximabS Galimberti, F Guerrini, F Morabito, et al.
Bone Marrow Transplantation|April 30, 2002
The role of molecular monitoring in autotransplantation for non-Hodgkin's lymphomaS Galimberti, R Marasca, F Caracciolo, et al.
Journal of Chemotherapy (Florence, Italy)|June 28, 2007
The efficacy of rituximab plus Hyper-CVAD regimen in mantle cell lymphoma is independent of FCgammaRIIIa and FCgammaRIIa polymorphismsS Galimberti, G A Palumbo, F Caracciolo, et al.
Leukemia Research|July 17, 2007
PS-341 (Bortezomib) inhibits proliferation and induces apoptosis of megakaryoblastic MO7-e cellsS Galimberti, M Canestraro, S Pacini, et al.
Pageof 3